The CEO’s comments
Medican was founded in 2017 with a clear vision to create a better quality of life for patients by offering medical cannabis as an alternative and/or a complement to prescription drugs. Medican received the EU-GMP certification in 2021 and have at current stage two approved products available in Germany while new strains and dosing forms are being developed in-house and with strategic partners.
The legalization of medical cannabis continues in Europe and Medican follows each country closely in order to meet patients’ needs and is currently working on marketing authorization in four other EU-countries.
Our dedicated team and sophisticated indoor growing facility are prepared for the future and Medican will show the way for medical cannabis where quality and availability for all patients are key drivers.
With Medican’s vision to improve the quality of life for patients by cultivating consistent, natural, high-quality medical cannabis with compassion and integrity, we all work hard to make sure the vision comes through.
Chief Executive Officer, Medican A/S